Demographic or disease characteristic | Number of subjects (N = 48) |
---|---|
Sex, n (%) | Â |
 Female | 21 (44) |
 Male | 27 (56) |
Race, n (%) | Â |
 White | 33 (69) |
 Nonwhite | 15 (31) |
  Asian | 1 (2) |
  Black or African American | 13 (27) |
  Multiracial | 1 (2) |
Age, years | Â |
 Mean (standard deviation) | 61.6 (11.2) |
 Median | 62 |
 Range | 39–81 |
Age, n (%) | Â |
 18–64 years | 30 (63) |
 ≥65 years | 18 (38) |
ECOG performance status, n (%) | Â |
 0 | 12 (25) |
 1 | 31 (65) |
 2 | 5 (10) |
Prior chemotherapy regimens, n (%) | Â |
 ≤2 | 16 (33) |
 3–5 | 23 (48) |
 ≥6 | 9 (19) |
Cancer type, n | Â |
 Colorectal | 15 |
 NSCLC | 5 |
 Ovarian | 4 |
 Breast, melanoma | 3 each |
 Prostate, cholangiocarcinoma, adenoid cystic, sarcoma, pancreatic, neuroendocrine | 2 each |
 Esophageal, gastric, gastrointestinal stromal tumor, hepatocellular, pseudomyxoma peritonei, vulvar | 1 each |